Tocqueville Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Tocqueville Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-80,920	Closed	-$4.98M	–	829
2018 Q3	$4.98M	Sell	80,920 -3,245	-4%	-$209K	0.06%	286
2018 Q2	$5.68M	Buy	84,165 +18,060	+27%	+$1.01M	0.07%	276
2018 Q1	$3.59M	Sell	66,105 -81,465	-55%	-$4.56M	0.05%	365
2017 Q4	$8.82M	Buy	147,570 +39,120	+36%	+$2.37M	0.1%	213
2017 Q3	$5.27M	Sell	108,450 -19,000	-15%	-$1.04M	0.06%	303
2017 Q2	$6.7M	Buy	127,450 +36,550	+40%	+$1.7M	0.08%	255
2017 Q1	$4.12M	Buy	90,900 +15,000	+20%	+$669K	0.05%	326
2016 Q4	$2.87M	Sell	75,900 -11,000	-13%	-$416K	0.04%	364
2016 Q3	$3.28M	Buy	86,900 +44,600	+105%	+$984K	0.04%	352
2016 Q2	$744K	Buy	42,300 +725	+2%	+$11.7K	0.01%	551
2016 Q1	$506K	Buy	41,575 +2,175	+6%	+$34.4K	0.01%	627
2015 Q4	$959K	Buy	39,400 +12,000	+44%	+$280K	0.01%	554
2015 Q3	$486K	Buy	+27,400	New	+$496K	0.01%	705
2015 Q2	–	Sell	-13,112	Closed	-$411K	–	1012
2015 Q1	$411K	Buy	13,112 +5,000	+62%	+$145K	﹤0.01%	757
2014 Q4	$237K	Buy	+8,112	New	+$206K	﹤0.01%	866

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tocqueville Asset Management's AERI Position: Q4 2018 in Review

Tocqueville Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2018, closing a stake of 80,920 shares — an estimated $4.98M sold.

Tocqueville Asset Management first reported a position in AERI in Q4 2014 and held it in 15 quarters. The position peaked at $8.82M in Q4 2017. 160 funds tracked by Wall St. Rank hold AERI as of Q4 2018.

Tocqueville Asset Management reported no remaining Aerie Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Tocqueville Asset Management sold 80,920 Aerie Pharmaceuticals shares in Q4 2018, an estimated $4.98M.
Tocqueville Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 15 quarters.
Tocqueville Asset Management's Aerie Pharmaceuticals position peaked at $8.82M in Q4 2017.
160 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2018.

Based on Tocqueville Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.